vs
bioAffinity Technologies, Inc.（BIAF）与Inotiv, Inc.（NOTV）财务数据对比。点击上方公司名可切换其他公司
Inotiv, Inc.的季度营收约是bioAffinity Technologies, Inc.的75.9倍（$120.9M vs $1.6M）。Inotiv, Inc.净利率更高（-23.5% vs -197.0%，领先173.5%）。Inotiv, Inc.同比增速更快（0.8% vs -27.8%）。bioAffinity Technologies, Inc.自由现金流更多（$-2.6M vs $-10.6M）。过去两年Inotiv, Inc.的营收复合增速更高（0.8% vs -18.6%）
bioAffinity Technologies是一家处于临床阶段的生物技术企业，专注于研发可用于癌症、呼吸系统疾病早期检测的非侵入性体外诊断产品，面向全球医疗市场，致力于提供高准确率的便捷诊断方案，改善患者诊疗体验与预后效果。
Inotiv公司是一家注册于美国印第安纳州的合同研究组织，总部位于该州拉斐特市。公司设有两大核心业务板块：发现与安全评估业务（DSA）以及研究模型与服务业务（RMS），可为小分子候选药物、生物治疗产品及生物医疗设备提供安全评估、分析、代谢研究、CMC及法规咨询等药物开发与环境科学相关服务。
BIAF vs NOTV — 直观对比
营收规模更大
NOTV
是对方的75.9倍
$1.6M
营收增速更快
NOTV
高出28.7%
-27.8%
净利率更高
NOTV
高出173.5%
-197.0%
自由现金流更多
BIAF
多$8.1M
$-10.6M
两年增速更快
NOTV
近两年复合增速
-18.6%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $120.9M |
| 净利润 | $-3.1M | $-28.4M |
| 毛利率 | — | — |
| 营业利润率 | -196.9% | -13.5% |
| 净利率 | -197.0% | -23.5% |
| 营收同比 | -27.8% | 0.8% |
| 净利润同比 | -5.7% | -2.7% |
| 每股收益（稀释后） | $-3.59 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIAFNOTV
| Q4 25 | $1.6M | $120.9M | ||
| Q3 25 | $1.4M | $138.1M | ||
| Q2 25 | $1.3M | $130.7M | ||
| Q1 25 | $1.9M | $124.3M | ||
| Q4 24 | $2.2M | $119.9M | ||
| Q3 24 | $2.4M | $130.4M | ||
| Q2 24 | $2.4M | $105.8M | ||
| Q1 24 | $2.4M | $119.0M |
净利润BIAFNOTV
| Q4 25 | $-3.1M | $-28.4M | ||
| Q3 25 | $-5.1M | $-8.6M | ||
| Q2 25 | $-4.1M | $-17.6M | ||
| Q1 25 | $-2.7M | $-14.9M | ||
| Q4 24 | $-3.0M | $-27.6M | ||
| Q3 24 | $-2.0M | $-18.9M | ||
| Q2 24 | $-2.1M | $-26.1M | ||
| Q1 24 | $-2.0M | $-48.1M |
营业利润率BIAFNOTV
| Q4 25 | -196.9% | -13.5% | ||
| Q3 25 | -158.6% | -4.9% | ||
| Q2 25 | -198.2% | -4.3% | ||
| Q1 25 | -141.7% | -2.4% | ||
| Q4 24 | -133.5% | -12.9% | ||
| Q3 24 | -84.0% | -10.1% | ||
| Q2 24 | -87.1% | -19.6% | ||
| Q1 24 | -80.8% | -36.2% |
净利率BIAFNOTV
| Q4 25 | -197.0% | -23.5% | ||
| Q3 25 | -349.3% | -6.2% | ||
| Q2 25 | -319.9% | -13.5% | ||
| Q1 25 | -143.5% | -12.0% | ||
| Q4 24 | -134.4% | -23.0% | ||
| Q3 24 | -85.1% | -14.5% | ||
| Q2 24 | -88.0% | -24.7% | ||
| Q1 24 | -81.5% | -40.4% |
每股收益（稀释后）BIAFNOTV
| Q4 25 | $-3.59 | $-0.83 | ||
| Q3 25 | $-4.74 | $-0.14 | ||
| Q2 25 | $-0.17 | $-0.51 | ||
| Q1 25 | $-0.16 | $-0.44 | ||
| Q4 24 | $-17.27 | $-1.02 | ||
| Q3 24 | $-4.84 | $-0.73 | ||
| Q2 24 | $-0.19 | $-1.00 | ||
| Q1 24 | $-0.20 | $-1.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $12.7M |
| 总债务越低越好 | — | $405.8M |
| 股东权益账面价值 | $7.3M | $109.0M |
| 总资产 | $11.0M | $734.3M |
| 负债/权益比越低杠杆越低 | — | 3.72× |
8季度趋势，按日历期对齐
现金及短期投资BIAFNOTV
| Q4 25 | $6.4M | $12.7M | ||
| Q3 25 | $7.7M | $21.7M | ||
| Q2 25 | $802.8K | $6.2M | ||
| Q1 25 | $444.7K | $19.3M | ||
| Q4 24 | $1.1M | $38.0M | ||
| Q3 24 | $756.6K | $21.4M | ||
| Q2 24 | $801.3K | $14.4M | ||
| Q1 24 | $2.5M | $32.7M |
总债务BIAFNOTV
| Q4 25 | — | $405.8M | ||
| Q3 25 | — | $402.1M | ||
| Q2 25 | — | $396.5M | ||
| Q1 25 | — | $399.5M | ||
| Q4 24 | — | $396.0M | ||
| Q3 24 | — | $393.3M | ||
| Q2 24 | — | $382.4M | ||
| Q1 24 | — | $380.6M |
股东权益BIAFNOTV
| Q4 25 | $7.3M | $109.0M | ||
| Q3 25 | $8.9M | $136.0M | ||
| Q2 25 | $-2.1M | $143.8M | ||
| Q1 25 | $1.4M | $157.7M | ||
| Q4 24 | $2.6M | $169.8M | ||
| Q3 24 | $3.1M | $170.5M | ||
| Q2 24 | $3.4M | $182.1M | ||
| Q1 24 | $5.3M | $207.2M |
总资产BIAFNOTV
| Q4 25 | $11.0M | $734.3M | ||
| Q3 25 | $11.5M | $771.1M | ||
| Q2 25 | $4.8M | $759.7M | ||
| Q1 25 | $5.5M | $766.0M | ||
| Q4 24 | $6.5M | $772.9M | ||
| Q3 24 | $6.6M | $781.4M | ||
| Q2 24 | $6.7M | $774.6M | ||
| Q1 24 | $8.0M | $815.4M |
负债/权益比BIAFNOTV
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | 2.76× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | — | 2.33× | ||
| Q3 24 | — | 2.31× | ||
| Q2 24 | — | 2.10× | ||
| Q1 24 | — | 1.84× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.6M | $-5.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | $-10.6M |
| 自由现金流率自由现金流/营收 | -160.7% | -8.8% |
| 资本支出强度资本支出/营收 | 0.0% | 4.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.4M | $-28.7M |
8季度趋势，按日历期对齐
经营现金流BIAFNOTV
| Q4 25 | $-2.6M | $-5.4M | ||
| Q3 25 | $-2.5M | $14.3M | ||
| Q2 25 | $-2.6M | $-7.4M | ||
| Q1 25 | $-1.6M | $-12.8M | ||
| Q4 24 | $-1.7M | $-4.5M | ||
| Q3 24 | $-1.7M | $-2.4M | ||
| Q2 24 | $-1.5M | $-14.8M | ||
| Q1 24 | $-2.3M | $16.9M |
自由现金流BIAFNOTV
| Q4 25 | $-2.6M | $-10.6M | ||
| Q3 25 | $-2.5M | $11.6M | ||
| Q2 25 | $-2.7M | $-11.5M | ||
| Q1 25 | $-1.7M | $-18.3M | ||
| Q4 24 | $-1.7M | $-9.0M | ||
| Q3 24 | $-1.7M | $-7.7M | ||
| Q2 24 | $-1.6M | $-19.2M | ||
| Q1 24 | $-2.4M | $9.9M |
自由现金流率BIAFNOTV
| Q4 25 | -160.7% | -8.8% | ||
| Q3 25 | -171.8% | 8.4% | ||
| Q2 25 | -209.6% | -8.8% | ||
| Q1 25 | -91.3% | -14.7% | ||
| Q4 24 | -76.0% | -7.5% | ||
| Q3 24 | -73.1% | -5.9% | ||
| Q2 24 | -65.1% | -18.2% | ||
| Q1 24 | -99.2% | 8.3% |
资本支出强度BIAFNOTV
| Q4 25 | 0.0% | 4.3% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 1.1% | 3.1% | ||
| Q1 25 | 2.7% | 4.4% | ||
| Q4 24 | 0.0% | 3.7% | ||
| Q3 24 | 0.4% | 4.1% | ||
| Q2 24 | 1.2% | 4.2% | ||
| Q1 24 | 1.7% | 5.9% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIAF
暂无分部数据
NOTV
| Research Models And Services Segment | $72.9M | 60% |
| Discovery And Safety Assessment Segment | $48.0M | 40% |
